Coupling Krebs cycle metabolites to signalling in immunity and cancer.
Accepted version
Peer-reviewed
Repository URI
Repository DOI
Change log
Authors
Abstract
Metabolic reprogramming has become a key focus for both immunologists and cancer biologists, with exciting advances providing new insights into underlying mechanisms of disease. Metabolites traditionally associated with bioenergetics or biosynthesis have been implicated in immunity and malignancy in transformed cells, with a particular focus on intermediates of the mitochondrial pathway known as the Krebs cycle. Among these, the intermediates succinate, fumarate, itaconate, 2-hydroxyglutarate isomers (D-2-hydroxyglutarate and L-2-hydroxyglutarate) and acetyl-CoA now have extensive evidence for "non-metabolic" signalling functions in both physiological immune contexts and in disease contexts, such as the initiation of carcinogenesis. This review will describe how metabolic reprogramming, with emphasis placed on these metabolites, leads to altered immune cell and transformed cell function. The latest findings are informative for new therapeutic approaches which could be transformative for a range of diseases.
Description
Keywords
Journal Title
Conference Name
Journal ISSN
2522-5812
Volume Title
Publisher
Publisher DOI
Sponsorship
Wellcome Trust (110159/Z/15/Z)
Medical Research Council (MC_UU_12022/6)
Medical Research Council (MC_U105663142)